Početna › Lupus › Texas › Houston
Kliničke studije za Lupus u gradu Houston, TX
13 studija za Lupus traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
U tijeku regrutacijaFaza 3
- Sl0044 50696, Houston
- Sl0044 50723, Houston
- Sl0044 50738, Bellaire · 7 mi udaljenosti
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
U tijeku regrutacijaFaza 2
- Prolato Clinical Research Center, Houston
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
U tijeku regrutacijaFaza 2
- The University of Texas Health Science Center at Houston, Houston
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
U tijeku regrutacijaFaza 3
- Novel Research LLC, Bellaire · 7 mi udaljenosti
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
U tijeku regrutacijaFaza 3
- Research Site, Houston
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
U tijeku regrutacijaFaza 3
- Research Site, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
U tijeku regrutacijaFaza 1
- UT MD Anderson Cancer Center, Houston
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
U tijeku regrutacijaFaza 1
- Baylor College of Medicine, Houston
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
U tijeku regrutacijaFaza 3
- Accurate Clinical Research, Humble · 17 mi udaljenosti
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
U tijeku regrutacijaFaza 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
U tijeku regrutacijaFaza 3
- Novel Research, LLC., Houston
- Northwest Houston Arthritis, Houston
- Rheumatology Care Center, PLLC, Bellaire · 7 mi udaljenosti
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
U tijeku regrutacijaOpažajna studija
- M D Anderson Cancer Center, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
U tijeku regrutacijaFaza 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Studije za Lupus u drugim gradovima
- New York City, NY18 studija
- Durham, NC12 studija
- Washington, DC10 studija
- Miami, FL10 studija
- Tampa, FL9 studija
- Philadelphia, PA9 studija
- Clearwater, FL8 studija
- Santa Monica, CA8 studija
- Oklahoma City, OK8 studija
- Boston, MA8 studija
- Los Angeles, CA8 studija
- Chicago, IL8 studija
Ostale studije u gradu Houston
- Nemikrocelularni karcinom pluća145 studija
- Rak dojke126 studija
- Rak (sve vrste)121 studija
- Metastatski karcinom104 studija
- Kolorektalni rak102 studija
- Rak jajnika89 studija
- Akutna mijeloična leukemija85 studija
- Rak pluća78 studija
- Rak prostate76 studija
- Rak endometrija68 studija
- Rak gušterače61 studija
- Melanom59 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.